Loading...

Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer

The anti-angiogenic agent bevacizumab has been approved for the treatment of non-small cell lung cancer, although the survival benefit associated with this agent is marginal, and toxicities and cost are substantial. A recent screen for selective inhibitors of endothelial cell proliferation identifie...

Full description

Saved in:
Bibliographic Details
Main Authors: Aftab, Blake T., Dobromilskaya, Irina, Liu, Jun O., Rudin, Charles M.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206167/
https://ncbi.nlm.nih.gov/pubmed/21896639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0691
Tags: Add Tag
No Tags, Be the first to tag this record!